Treatment.com AI IncCanadian Securities Exchange:TRUEView on OTCQB
- LAST PRICE0.7100
- TODAY'S CHANGE (%)-0.0100 (-1.3889%)
- Bid / Lots0.7100/ 5
- Ask / Lots0.7500/ 52
- Open / Previous Close0.7200 / 0.7200
- Day Range
- 52 Week Range
- Volume30,820
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TRUE |
|---|---|---|
| 10:35 ET | 14500 | 0.72 |
| 11:11 ET | 500 | 0.73 |
| 12:07 ET | 1000 | 0.73 |
| 01:14 ET | 500 | 0.73 |
| 01:30 ET | 1000 | 0.73 |
| 03:03 ET | 2500 | 0.73 |
| 03:14 ET | 4000 | 0.73 |
| 03:23 ET | 3000 | 0.73 |
| 03:57 ET | 3000 | 0.71 |
Apr 17, 2024
Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES), from 8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 17, 2024 by Dow JonesTreatment.com AI Announces New Additions to its Medical Education Suite (MES), from 3:05AM ET on Wednesday Apr 17, 2024 by Dow Jones
3:05AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 10, 2024
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM), from 6:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
6:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 8, 2024
Mar 27, 2024
Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity, from 8:00AM ET on Wednesday Mar 27, 2024 by Dow Jones
8:00AM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Treatment.com AI Inc | 27.8M | -2.0x | --- |
Cannabix Technologies Inc | 28.5M | -12.5x | --- |
Medx Health Corp | 24.9M | -3.3x | --- |
VentriPoint Diagnostics Ltd | 33.8M | -7.1x | --- |
Theralase Technologies Inc | 35.7M | -7.7x | --- |
Groupe Ryah Inc | 11.2M | 2.2x | --- |
Company Information
Treatment.com AI Inc., through its wholly owned subsidiary, Treatment.com Inc., is in the business of providing personalized health care information. The Company has developed a personalized healthcare artificial intelligence (AI) engine, the Global Library of Medicine (GLM), which is engaged in providing clinical information and support to all healthcare professionals. The GLM delivers over 92% accuracy on first diagnosis as well as providing recommended tests (physical and lab), x-rays, and billing codes. Its solutions include medical education solution, medical clinic solution and clinical advisor solution. It also focuses on the next generation of healthcare professionals supporting medical and nursing schools, who utilize the GLM to help improve the clinical skills of their students. It is also focused on using AI for utilizing its GLM platform to bring the possibility of health equity and inclusion for disenfranchised communities.
Contact Information
- Headquarters
- 8500 Normandale Lake Boulevard Suite 350BLOOMINGTON, MN, United States 55437
- Phone
- 612-788-8900
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $27.8M |
|---|---|
Revenue (TTM) | $38.1K |
Shares Outstanding | 39.2M |
Treatment.com AI Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.35 |
Book Value | $-0.33 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 730.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,231.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
